ArticleFrontiers in immunology2024

Effectiveness of COVID-19 XBB.1.5 monovalent mRNA vaccine in Korea: interim analysis.

Eliel Nham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.